A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

NCT07355218 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Systematic Lupus Erythematosus
Cutaneous Lupus Erythematosus

Interventions

DRUG: Enpatoran
DRUG: Placebo
DRUG: Standard of care (SoC)

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]